INS and Hypoglycemia: This study demonstrated that hypoglycemia occurring during use of PLGS may require less CHO treatment than currently recommended by clinical guidelines.9,12 This is illustrated by the limited number of instances of CHO used to treat hypoglycemia and by calculating the CHO averted based upon the decrement in programmed basal insulin preceding these episodes.